Body fat reduction without cardiovascular changes in mice after oral treatment with the MAO inhibitor phenelzine.

As phenelzine reduced body fat content without affecting cardiovascular function in mice, it may be of benefit in the treatment of obesity-associated complications, with the precautions of use recommended for antidepressant therapy.